-+ 0.00%
-+ 0.00%
-+ 0.00%

Invion Doses First Patient in Phase I/II Skin Cancer Trial

ASX·12/02/2024 22:04:56

The content of this announcement was automatically generated by machine and is for reference only. The original announcement can be viewed by clicking on the link below.